The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous work has shown that random sequence ssDNA can bind with high affinity to phospholamban resulting in increased SERCA activity in solution studies8, 20.”
From Cytoplasmic nucleic acid-based XNAs directly enhance live cardiac cell function by a Ca2+ cycling-independent mechanism via the sarcomere (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional screening identifies miRNAs inducing cardiac regeneration
Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., & Giacca, M. (2012) · Nature · doi:10.1038/nature11739 · Cited by 1,029
Research works printed but not linked: 51
- Bers, 2002, Cardiac excitation-contraction coupling, Nature, 415, 198, 10.1038/415198a · DOI · Paper page
- Bers, 2008, Calcium cycling and signaling in cardiac myocytes, Annu. Rev. Physiol, 70, 23, 10.1146/annurev.physiol.70.113006.100455 · DOI · Paper page
- Heidenreich, 2011, Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association, Circulation, 123, 933, 10.1161/CIR.0b013e31820a55f5 · DOI · Paper page
- Gwathmey, 2013, Targeting sarcoplasmic reticulum calcium ATPase by gene therapy, Hum. Gene. Ther, 24, 937, 10.1089/hum.2013.2512 · DOI
- Jessup, 2011, Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure, Circulation, 124, 304, 10.1161/CIRCULATIONAHA.111.022889 · DOI · Paper page
- Kairouz, 2012, Molecular targets in heart failure gene therapy: current controversies and translational perspectives, Ann. N. Y. Acad. Sci, 1254, 42, 10.1111/j.1749-6632.2012.06520.x · DOI
- Møller, 2010, The sarcoplasmic Ca2+-ATPase: design of a perfect chemi-osmotic pump, Q. Rev. Biophys, 43, 501, 10.1017/S003358351000017X · DOI · Paper page
- Simmerman, 1986, Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains, J. Biol. Chem, 261, 13333, 10.1016/S0021-9258(18)69309-3 · doi:10.1016/s0021-9258(18)69309-3
- Simmerman, 1998, Phospholamban: protein structure, mechanism of action, and role in cardiac function, Physiol. Rev, 78, 921, 10.1152/physrev.1998.78.4.921 · DOI · Paper page
- Tada, 1975, Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′:5′-monophosphate-dependent protein kinase, J. Biol. Chem, 250, 2640, 10.1016/S0021-9258(19)41650-5 · DOI · Paper page
- Soller, 2015, Rheostatic regulation of the SERCA/phospholamban membrane protein complex using non-coding RNA and single-stranded DNA oligonucleotides, Sci. Rep, 5, 13000, 10.1038/srep13000 · DOI · Paper page
- Sayed, 2011, MicroRNAs in development and disease, Physiol. Rev, 91, 827, 10.1152/physrev.00006.2010 · DOI · Paper page
- Zhao, 2005, Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis, Nature, 436, 214, 10.1038/nature03817 · DOI · Paper page
- Zhao, 2007, Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1–2, Cell, 129, 303, 10.1016/j.cell.2007.03.030 · DOI · Paper page
- Zhou, 2014, MicroRNAs in diabetic cardiomyopathy and clinical perspectives, Front. Genet, 5, 185, 10.3389/fgene.2014.00185 · DOI
- Bao, 2013, Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells, Int. J. Mol. Sci, 14, 23086, 10.3390/ijms141123086 · DOI · Paper page
- Mishra, 2009, MicroRNAs as a therapeutic target for cardiovascular diseases, J. Cell. Mol. Med, 13, 778, 10.1111/j.1582-4934.2009.00744.x · DOI
- Tijsen, 2012, Non-cardiomyocyte microRNAs in heart failure, Cardiovasc. Res, 93, 573, 10.1093/cvr/cvr344 · DOI
- Wijnen, 2014, Cardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy, PLoS One, 9, e96290, 10.1371/journal.pone.0096290 · DOI
- Mishra, 2013, Cardiac matrix: a clue for future therapy, Biochim. Biophys. Acta, 1832, 2271, 10.1016/j.bbadis.2013.09.004 · DOI
- Halkein, 2013, MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy, J. Clin. Invest, 123, 2143, 10.1172/JCI64365 · DOI · Paper page
- Keklikoglou, 2015, MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes, Oncogene, 34, 4867, 10.1038/onc.2014.408 · DOI
- Madden, 1979, Cholesterol modulates activity of calcium-dependent ATPase of the sarcoplasmic reticulum, Nature, 279, 538, 10.1038/279538a0 · DOI
- Gustavsson, 2011, Activating and deactivating roles of lipid bilayers on the Ca2+-ATPase/phospholamban complex, Biochemistry, 50, 10367, 10.1021/bi200759y · DOI · Paper page
- Datta, 2003, Salt dependence of DNA binding by Thermus aquaticus and Escherichia coli DNA polymerases, J. Biol. Chem, 278, 5694, 10.1074/jbc.M208133200 · DOI
- Datta, 2003, Thermodynamics of the binding of Thermus aquaticus DNA polymerase to primed-template DNA, Nucleic Acids Res, 31, 5590, 10.1093/nar/gkg774 · doi:10.1093/nar/gkg774
- Eom, 1996, Structure of Taq polymerase with DNA at the polymerase active site, Nature, 382, 278, 10.1038/382278a0 · DOI · Paper page
- Gottesfeld, 2001, Energetics and affinity of the histone octamer for defined DNA sequences, Biochemistry, 40, 10927, 10.1021/bi0109966 · DOI
- Luger, 1997, Crystal structure of the nucleosome core particle at 2.8 Å resolution, Nature, 389, 251, 10.1038/38444 · DOI · Paper page
- van Rooij, 2012, MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles, Nat. Rev. Drug Discov, 11, 860, 10.1038/nrd3864 · DOI · Paper page
- Bers, 2000, Calcium fluxes involved in control of cardiac myocyte contraction, Circ. Res, 87, 275, 10.1161/01.RES.87.4.275 · DOI · Paper page
- Cornea, 2013, High-throughput FRET assay yields allosteric SERCA activators, J. Biomol. Screen, 18, 97, 10.1177/1087057112456878 · DOI
- Gruber, 2014, Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells, J. Biomol. Screen, 19, 215, 10.1177/1087057113510740 · DOI
- Li, 1998, Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects, Am. J. Physiol, 274, H1335
- Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A, Proc. Natl. Acad. Sci. U.S.A, 108, 2735, 10.1073/pnas.1013987108 · DOI
- Vostrikov, 2015, Effects of naturally occurring arginine 14 deletion on phospholamban conformational dynamics and membrane interactions, Biochim. Biophys. Acta, 1848, 315, 10.1016/j.bbamem.2014.09.007 · DOI
- Ceholski, 2012, Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy, J. Biol. Chem, 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U.S.A, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- van der Zwaag, 2012, Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy, Eur. J. Heart Fail, 14, 1199, 10.1093/eurjhf/hfs119 · DOI · Paper page
- Bai, 2013, Phospholamban knockout breaks arrhythmogenic Ca2+ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice, Circ. Res, 113, 517, 10.1161/CIRCRESAHA.113.301678 · doi:10.1161/circresaha.113.301678
- Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
- Ha, 2007, Controlling the inhibition of the sarcoplasmic Ca2+-ATPase by tuning phospholamban structural dynamics, J. Biol. Chem, 282, 37205, 10.1074/jbc.M704056200 · DOI
- Ha, 2012, Tuning the structural coupling between the transmembrane and cytoplasmic domains of phospholamban to control sarcoplasmic reticulum Ca2+-ATPase (SERCA) function, J. Muscle Res. Cell Motil, 33, 485, 10.1007/s10974-012-9319-4 · DOI
- Größl, 2014, A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum, PLoS One, 9, e92188, 10.1371/journal.pone.0092188 · DOI
- Cheng, 2007, MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy?, Am. J. Pathol, 170, 1831, 10.2353/ajpath.2007.061170 · DOI · Paper page
- Tatsuguchi, 2007, Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy, J. Mol. Cell. Cardiol, 42, 1137, 10.1016/j.yjmcc.2007.04.004 · DOI · Paper page
- Li, 2010, Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy, J. Cell Sci, 123, 2444, 10.1242/jcs.067165 · DOI
- Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expr. Purif, 30, 253, 10.1016/S1046-5928(03)00127-X · DOI · Paper page
- Stokes, 1990, Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing, Biophys. J, 57, 1, 10.1016/S0006-3495(90)82501-7 · DOI
- Shackman, 2004, High-throughput automated post-processing of separation data, J. Chromatogr. A, 1040, 273, 10.1016/j.chroma.2004.04.004 · doi:10.1016/j.chroma.2004.04.004
- Jing, 2011, Methods for measuring aptamer-protein equilibria: a review, Anal. Chim. Acta, 686, 9, 10.1016/j.aca.2010.10.032 · DOI · Paper page
Cited by
Weber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184370 · Cited by 8
Self-citationThompson, B. R., Soller, K. J., Vetter, A., Yang, J., Veglia, G., Bowser, M. T., & Metzger, J. M. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.02.016 · Cited by 2
Self-citation
Metadata
- Authors
- Soller, K. J., Yang, J., Veglia, G., & Bowser, M. T.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 291
- Issue
- 41
- Pages
- 21510-21518
- ISSN
- 0021-9258
- Cited by
- 17
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 1433 d)
- Funders
- National Institutes of Health (GM063533, GM072701)
- American Heart Association (13PRE16950023)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs. https://app.cochat.ai/papers/10.1074/jbc.m116.738807
- The paper
- Soller, K. J., Yang, J., Veglia, G., & Bowser, M. T. (2016). Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m116.738807
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.